“President Trump ‘s nominee to head the Food and Drug Administration (FDA) cleared a key Senate panel Tuesday with bipartisan support.”
“If confirmed by the full Senate, cancer doctor and researcher Stephen Hahn would join the FDA at a challenging time: The agency is facing pressure from all sides on how to curb youth vaping rates, with some pushing for a ban on flavored e-cigarette products.”
“Hahn, the chief medical officer of MD Anderson Cancer Center in Houston, hasn’t weighed in on specific proposals…”
“When asked about that proposal during his November confirmation hearing, Hahn wouldn’t comment on specifics, saying he would use “science and data” to tackle youth vaping rates…” Read the full article here.
Source: Trump’s FDA nominee approved by Senate panel – By Jessie Hellmann, December 3, 2019. The Hill.
